C
ONGESTIVE HEART FAILURE (CHF) is a growing health issue, with significant morbidity and mortality. Of the 5.8 million Americans affected by CHF, approximately one third of these suffer from nonischemic cardiomyopathy. 1 Left ventricular assist devices (LVADs) provide mechanical support to the heart and potentially can reverse the progression of heart failure. 2,3 LVAD therapy improves heart failure symptoms by 1 to 2 New York Heart Association classes, improves hepatic and renal function, and can improve patient functional capacity. More than 5,000 patients have received a Heartmate II (Thoratec Corp, Pleasanton, CA) LVAD since 2005. 2 As the success of LVAD therapy grows, it can be expected to see these patients return to the operating room with increasing frequency for noncardiac procedures. Anesthetic management of LVAD patients for open surgical procedures has been discussed in detail in prior literature [3] [4] [5] ; however, there is a void concerning management for laparoscopic procedures. 6 The anesthetic management for laparoscopic gastric bypass in a patient with an LVAD is reported. Verbal consent was obtained from the patient before writing this case report.
CASE REPORT
A 38-year-old man developed nonischemic cardiomyopathy at the age of 30. Despite medical management, he progressed to class IV CHF requiring home inotropic support and eventually underwent LVAD implantation. After LVAD implantation, the patient's functional capacity increased, whereas the CHF symptoms decreased; however, morbid obesity (body mass index ϭ 53 kg/m 2 , weight ϭ 195 kg) made him ineligible for heart transplantation. As a result, 1.5 years after LVAD placement he was scheduled for laparoscopic Roux-en-Y gastric bypass surgery.
The patient's comorbidities included hypertension, obstructive sleep apnea requiring nightly continuous positive airway pressure, type-II diabetes mellitus, and a history of pulmonary embolism. He also suffered from a chronic LVAD driveline infection that was being treated with oral antibiotics and dressing changes. A biventricular pacemaker defibrillator was implanted 3 years earlier because of heart failure. A preoperative echocardiogram revealed 4-chamber enlargement, mild pulmonary hypertension, aortic valve opening with every heart beat, trivial aortic regurgitation, a left ventricular ejection fraction of 10%, good LVAD cannula position with unobstructed inflow and outflow, and mildly decreased right ventricular function. LVAD assessment showed an average flow of 6.6 L/min. Medications included trimethoprim/sulfamethoxazole, ciprofloxacin, spironolactone, aspirin, warfarin, metoprolol, glimepiride, and furosemide.
The case originally was scheduled to be performed in a universityaffiliated community hospital where bariatric cases are commonly performed, but after thorough communication among the surgeon, the heart failure service, and anesthesiologists at both hospitals, it was decided to perform the operation at the university hospital where ventricular assist device support and other resources were more immediately available. The patient was admitted to the hospital 3 days before surgery to begin intravenous antibiotics for his driveline infection and to transition from warfarin to heparin anticoagulation. On admission, his international normalized ratio was 2.3, his prothrombin time was 25.8 seconds, and his partial thromboplastin time was 39.5 seconds, whereas on the morning of surgery they were 1.4, 17.4 seconds, and 96 seconds, respectively. The anesthetic plan was discussed extensively with the patient and his family the day before surgery. Discussion among the anesthesia, surgical, perfusion, and nursing teams took place in the week before surgery.
In the preanesthesia area, the left radial artery was cannulated using anatomic landmarks and Doppler ultrasound mapping because there was no palpable pulse. A bolus of 1,000 mL of lactated Ringers was infused over 40 minutes to augment preload. The defibrillator was interrogated, pacing was changed to an asynchronous mode, and antitachycardia features were turned off. External defibrillator pads were placed, and the patient was transported to the operating room by the anesthesiologist and perfusionist.
After thorough preoxygenation, anesthesia was induced with 300 g of fentanyl, 100 mg of lidocaine, 30 mg of etomidate, and 200 mg of succinylcholine. Direct laryngoscopy with a Miller 3 blade and placement of an 8.0 endotracheal tube followed. There were no hemodynamic changes noted during the induction period. A 9F introducer and pulmonary artery catheter were placed under ultrasound guidance via the right internal jugular vein. A milrinone infusion of 0.5 g/kg/min was used to augment right ventricular function and provide pulmonary vasodilatation. Anesthesia was maintained with isoflurane in 80% oxygen and a remifentanil infusion. Vecuronium was titrated for muscle relaxation, and the patient was ventilated by volume control with a target end-tidal carbon dioxide between 35 and 40 mmHg. Before surgical incision, the patient was hemodynamically stable with LVAD flows of 5.9 L/min, a mixed venous oxygen saturation (SvO 2 ) of 75%, cardiac index (CI) of 2.5 L/min/m 2 , pulmonary artery pressures (PAP) of 43/26 mmHg, a mean arterial pressure (MAP) of 85 mmHg, central venous pressure (CVP) of 14 mmHg, tidal volume of 800 mL with a peak inspiratory pressure of 30 cmH 2 0, and an end-tidal carbon dioxide of 38 mmHg. Transesophageal echocardiography was available but would interfere with the surgical procedure; therefore, it was reserved for emergency use.
Ultrasound imaging was used by the surgeon to plan surgical incision sites away from the LVAD driveline, which traversed within the pro-peritoneal space in the upper left abdominal quadrant. Initial incisions and pneumoperitoneum to 15 mmHg were well tolerated by the patient, with a MAP of 90 mmHg, a CVP of 14 mmHg, a PAP of 43/27 mmHg, and LVAD flow of 6.1 L/min. The ventilation rate was increased to avoid hypercarbia, and peak pressures were noted to increase to 35 cmH 2 O. Portions of the operation required the patient to be placed in the steep reverse Trendelenburg position, which was achieved incrementally. During the initial position change, the LVAD flows decreased to 4.9 L/min, SvO 2 decreased to 69%, CI to 1.8 L/min/m 2 , and MAP decreased to 73 mmHg. The patient was returned to a level position, and additional fluid was given to augment preload while factors that may have been increasing pulmonary vascular resistance were reassessed. The authors were then able to position the patient and complete the
